Cytovation Identifies Unique Peptide For Treatment Of Cutaneous Warts
Emerging Company Profile: After an early quiet period, Norway's Cytovation has raised funds locally in the past year to support initial clinical studies of a potential first-in-class viralytic and oncolytic peptide.
